View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
In patients with acute coronary syndromes, short-term use of clopidogrel (Plavix) and aspirin reduces ischemic events. But these drugs also increase the risk of bleeding in patients who need surgery. Assessing the risk in patients undergoing coronary artery bypass graft (CABG) surgery, researchers found that clopidogrel use within 5 days before CABG surgery "was not significantly associated with reoperation for bleeding[horizontal ellipsis] and only weakly with red cell transfusion after surgery." They based their findings on an analysis of bleeding events among 4,794 patients undergoing CABG surgery.
Researchers caution clinicians that a decision about whether or not to withhold clopidogrel in a patient who's benefited from the drug should be made in the context of other bleeding determinants, such as the use of cardiopulmonary bypass during surgery.
Source: Kim JH, Newby LK, Clare RM, et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. Am Heart J. 2008;156(5):886-892.
Find in-depth content on major issues provided by leading companies in partnership with NursingCenter.com
BD Safety Beyond Needlestick Prevention Learning Center
Sponsored by BD Medical
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top